Re dilution, yes, that's how these things work. Once the listing is restored and the clinical trials begin, it is a race to respectability. The longer it takes to get there, the more dilution destroys the original investors.
This was always a long-shot bet. It is a miracle that we are (a) still in the game, and (b) basically whole, if not slightly ahead, if the share price doesn't collapse. That is nothing short of amazing. Of course, it could easily go the other way too, and in a big way, if the trials go well. The share count is now absurdly low, and this will be a very attractive target if the science comes through.
The bad news is that my shares with Schwab still do not reflect the reverse split, and I am having a heck of a time forcing the issue. I had an animated discussion with a Schwab rep today, and insisted that they elevate this issue and create a formal inquiry. They finally agreed. No room for nonsense anymore. I also sent a new E-Mail to the CFO, and a separate message to Securities Transfer Corporation. I will be on this daily until the issue is resolved. Too much money on the line here to put up with deflections and BS any longer.
If anyone has shares with a broker, and those shares now reflect the 1:26 split, please post here to let us know which broker. This is critical information. We cannot allow brokerage shares to get lost in this transition. If I don't see a resolution to this soon, the next step, unfortunately, will be lawyers.
